24 April 2025NewsAmericasDean Pelletier

Strategic IP protection for biotech-related GenAI

Generative AI is transforming the biotech industry, so it’s crucial to have an IP strategy—in particular, for trade secret and/or patent protection. Dean Pelletier of Pelletier Law explains.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

EPO: Biotech innovation strong, while pharma trails behind

8 April 2025 According to the Patent Index 2024, patent filings remained high in Europe last year “despite political and economic uncertainties” | Johnson & Johnson ranked among the top requesters of unitary patents.

Americas

LSPN chair: Uncertainty lies ahead for life sciences

8 April 2025 Ahead of the upcoming LSPN North America-Spring 2025 conference, chair Eldora Ellison shares insights on emerging innovations in AI and gene editing, and offers advice for thriving in a competitive environment.

Americas

Patent attorneys by day, coders by night: Sterne Kessler launches ‘homemade’ AI assistant

3 April 2025 The IP specialist bypassed vendors and turned to its own ‘tech geeks’ to create an in-house AI solution for drafting patent applications. LSIPR meets the attorney coders doing it for themselves.